Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 12/20 | 0.46 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.45 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.45 |
| ▸ | RIPK3 | Q9Y572 | 2/20 | 0.45 |
| ▸ | CSF1R | P07333 | 2/20 | 0.44 |
| ▸ | ROR1 | Q01973 | 3/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.39 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.39 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.39 |
| ▸ | FGFR3 | P22607 | 2/20 | 0.39 |
| ▸ | ABL2 | P42684 | 2/20 | 0.38 |
| ▸ | GAK | O14976 | 1/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17471701 | 0.92 | RIPK1 (0.52) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL17471724 | 0.91 | RIPK1 (0.52) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL17471734 | 0.90 | ABL1 (0.46) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL17471712 | 0.84 | ABL1 (0.51) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL17471706 | 0.81 | RIPK1 (0.52) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL16085054 | 0.81 | RIPK1 (0.52) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL17471723 | 0.80 | RIPK1 (0.52) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL17471718 | 0.80 | ABL1 (0.52) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL17471714 | 0.78 | ABL1 (0.54) | ABL1RIPK1RIPK2RIPK3CSF1R | |
| SCHEMBL16085004 | 0.74 | CSF1R (0.63) | ABL1RIPK1RIPK2RIPK3CSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160024098-A1 | HYBRID NECROPTOSIS INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-28 | — | — | US | disclosed |
| US-20160024098-A1 | HYBRID NECROPTOSIS INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024098-A1 | HYBRID NECROPTOSIS INHIBITORS | RIPK3, RIPK1, RIPK4 | ABL1 1547/4885RIPK1 2/4885RIPK2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.